Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conf
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.